维普中文期刊产品整合服务
120篇 您的检索式:作者名="Barlesi F"
    题名 作者 年代 出处 被引量
1Video-assisted ehoracoscopic management of recurrent primary spontaneous pneumothorax after prior talc pleurodesis:a Peasible,safe and efficient treatment option显示文摘Doddli C Barlesi F Raticelli A 2004Eur J Card Thorac Surg2004,26,5:1
2Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase Ⅲ rando- mized trials 显示文摘Pujol JL Barlesi F Daures JP 2006Lung Cancer2006,51,3:1
3CYFRA 21-1 level pre- dicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy显示文摘Barlesi F Tchouhadjian C Doddoli C 2005Br J Cancer2005,92,1:1
4Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase Ⅲ trials显示文摘Barlesi F Pujol JL 2005Lung Cancer2005,49,3:1
5Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer:a systematic review of phase Ⅲ trials显示文摘Barlesi F Pujol JL 2005Lung Cancer2005,49,3:1
6Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)显示文摘Vansteenkiste J Barlesi F Waller CF 2015Ann Oncol2015,26,8:1
7Maintenance bevacizumab - pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsqua- mous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase m trial 显示文摘Barlesi F Scherpereel A Gorbunova V 2014Ann Oncol2014,25,5:1
8Neurocognitive func- tion impairment after whole brain radiotherapy for brain me- tastases: actual assessment显示文摘Tallet AV Azria D Barlesi F 2012Radiat Oncol2012,7,1:1
9Second line therapy with gefitinib in combination with doeetaxel for advanced non-small cell lung cancer: a phase Ⅱ randomized study显示文摘Robinet G Barlesi F Fournel P 2007Targ Oncoh2007,2,2:1
10Translational Research: Precision Medicine, Personalized Medicine,Targeted Therapies: Marketing or Science?显示文摘Marquet P Longeray PH Barlesi F 2015Thérapie2015,70,1:1
11Gemcitabine-induced severe pulmonary toxicity 显示文摘 Villani P Doddoli C 2004Fundam Clin Pharmacol2004,18,1:1
12Neurocognitive function impairment after whole brain radiotherapy for brain metastases:actual assessment显示文摘Tallet AV Azria D Barlesi F 2012Radiat Oncol2012,7,:1
13Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer显示文摘Doddoli C Aragon A Barlesi F 0,,04:1
14Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer 显示文摘Barlesi F Gimenez C Torre JP 2004Respir Med2004,98,4:1
15Targeted therapies in malignant pleural mesothelioma:a review of clinical studies显示文摘Greillier L Marco S Barlesi F 2011Anticaneer Drugs2011,22,3:1
16Prognostic value of combination of Cyfra21-1, CEA and NSE in patients with advanced non-small cell lung cancer 显示文摘Barlesi F Gimenez C Torte JP 2004Respir ned2004,98,4:1
17Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non- small cell lung cancer 显示文摘Barlesi F Gimenez C Torre JP 2004Respir Med2004,98,4:1
18The place of excision repair cross complementatio-n 1(ERCC1)in surgically treated non-small cell lung cancer显示文摘Breen D Barlesi F 2008Eur JCardiothorac Surg2008,33,5:1
19Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer ( NSCLC ) with asymptomatic inoperable brain metastases:a multicenter phase Ⅱ trial (GFPC 07 01)显示文摘Barlesi F Gervais R Lena H 2011Ann Oncol2011,22,11:1
20An open muhicenter phase Ⅱ trial of weekly docetaxel for advanced-stage non-smallcell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study 显示文摘LeCaer H Barlesi F Robinet G 2007Lung Cancer2007,57,1:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费